Familiar Therapeutics raises $5 million in seed funding to enhance veterinary medicine using advancements from human healthcare. The funding round was led by Pioneer Fund, Icehouse Ventures, and BreakTHRU, along with participation from angel investors.
Amount Raised
$5 Million
Round Type
Seed
Redwood CityBiotechnologyHealth CareAnimal FeedPetVeterinaryInvestors
Description
Familiar Therapeutics launched today with $5 million in seed funding aimed at bridging the advances of human medicine for application in veterinary care. The funding will support innovative treatment options for chronic and life-threatening diseases in dogs and cats. Leading the round were Pioneer Fund, Icehouse Ventures, and BreakTHRU, alongside several angel investors. This initiative highlights a significant effort to improve animal health through modern medical advancements.
Who to call at Familiar Therapeutics, and when
A new round usually means Familiar Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Familiar Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Familiar Therapeutics, from your own LinkedIn network
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Familiar Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Familiar Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.